At a glance

What is epitalon?

Epitalon (also spelled epithalon) is a synthetic four-amino acid peptide derived from epithalamin, a natural extract of the pineal gland. It is sold through wellness and "research peptide" channels for anti-aging, longevity, and sleep, often described as a "peptide bioregulator." It is not an approved medicine.

How does it work?

Epitalon is proposed to:

• Help restore the body's melatonin rhythm¹
• Act as an antioxidant
• Influence gene expression, including claims of activating telomerase² (an enzyme linked to cellular aging)

These mechanistic claims rest on cell-culture and animal work, with the telomerase findings coming from laboratory systems. This describes the proposed mechanism, separate from demonstrated benefit in people.

Is it FDA-approved?

No. Epitalon is not approved by the FDA for any use. In July 2026 the FDA's Pharmacy Compounding Advisory Committee gave epitalon a narrow, non-binding favorable vote toward the 503A compounding list. Because that vote is only a recommendation and the FDA has not completed formal rulemaking, epitalon is not currently on the list and cannot be legally compounded by U.S. pharmacies on that basis.

What does the research show?

The human evidence is limited and single-source. The main human reports come from one Russian research group and include older studies on melatonin rhythm and age-related conditions; these are generally small, largely non-English, and not independently replicated with modern randomization and blinding. No independent, large, modern trial establishes a longevity or wellness benefit. The telomerase and lifespan³ claims rest mainly on laboratory and animal work.

Frequently asked questions

What is Epitalon?

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide with the amino acid sequence alanine-glutamic acid-aspartic acid-glycine (AEDG). It was developed by Vladimir Khavinson's laboratory at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic peptide designed from Epithalamin¹, a bovine pineal extract. Published research has examined putative effects on telomerase activity, circadian gene expression, and survival endpoints in animal models. It is not FDA-approved for any use in humans.

Does Epitalon activate telomerase in humans?

Epitalon has been shown to activate telomerase and elongate telomeres in human cell cultures, including a 2025 independent replication⁵ at Brunel University London. Whether this in-vitro effect translates to telomerase activation in living human tissues has not been established. No completed human clinical trial has measured telomere length before and after Epitalon administration under controlled conditions. The cell culture findings are meaningful as mechanistic evidence, but they do not confirm that Epitalon extends telomeres or activates telomerase in the bodies of people who use it.

Is Epitalon the same as Epithalamin?

No. Epithalamin is a polypeptide complex extracted from bovine pineal glands and studied by Russian researchers for decades¹. Epitalon is a synthetic tetrapeptide (AEDG) considered the putative active component⁶ of Epithalamin, designed from its amino acid composition. The human observational studies on longevity and cardiovascular aging that are often cited as evidence for Epitalon were conducted using Epithalamin, not synthetic AEDG. The two compounds are related but not identical, and the human data from Epithalamin trials cannot be directly attributed to synthetic Epitalon.

What does the human longevity data actually show?

The most-cited human longevity data for this compound family is a 6-8 year follow-up of 266 elderly persons treated with thymic and pineal peptide preparations (including Epithalamin), published by Khavinson and Morozov in 2003 in Neuroendocrinology Letters and available at PubMed⁷. The reported mortality reduction ranged from 1.6- to 4.1-fold versus controls, depending on regimen. Although PubMed indexes it as a randomized clinical trial, the abstract describes no blinding or placebo arm and reports no p-values; the study used the parent pineal extract rather than synthetic Epitalon, was conducted by the same group that developed the compound, and has not been independently replicated. These are significant methodological limitations that prevent the data from being treated as established clinical evidence.

Is Epitalon legal to buy in the United States?

As of September 2026, Epitalon is not a federally controlled substance⁸. It cannot legally be sold or marketed as a drug for human use without FDA approval. FDA removed Epitalon from its Category 2 list in April 2026 after the nomination was withdrawn, but it is not on the 503A bulks list or in FDA's Category 1⁹, so it is not eligible for 503A compounding. FDA's advisory committee voted 7-4 on July 24, 2026¹⁰ to recommend adding it for insomnia, the only use FDA evaluated⁶, a non-binding vote that still requires rulemaking. Research chemical vendors sell Epitalon without prescription; these products are not FDA-approved, so no FDA review has assessed their quality.

Are there side effects associated with Epitalon?

No clinical safety studies of Epitalon in humans⁶ have been identified in the published literature. The Russian observational cohort studies and animal studies do not document significant adverse events at the doses studied. The absence of reported harms does not establish safety; it reflects the absence of adequately controlled human safety data. The long-term effects of Epitalon administration in humans, including effects on cell proliferation and oncogenesis given its telomerase-activating mechanism, have not been systematically studied.

How does Epitalon compare to other longevity peptides?

Epitalon's published evidence base is heavily concentrated within a single Russian research network. MOTS-c, humanin, and related mitochondrial-derived peptides¹¹ are encoded in mitochondrial DNA and have a different mechanism of action. None of these compounds has completed a large-scale randomized controlled trial in humans demonstrating lifespan extension or reliable biological aging reversal. Comparing them based on current evidence would require treating animal and small in-vitro data as clinically equivalent, which they are not.

More for brain & sleep